USCAP Breast and Gynecological Pathology 2025
USCAP Breast and Gynecological Pathology 2025 is listed for pathologists reviewing breast lesions and female genital tract pathology, with an emphasis on morphology and ancillary diagnostic studies.
Store-listed recording release: April 11, 2025; not independently confirmed. The USCAP archive identifies the original live meeting as February 4–7, 2025. Meeting dates do not establish the recording release date or delivered file inventory.
Learning Objectives
The listed educational aims relate to the course period:
- Recognize updated diagnostic criteria and disease classifications in breast and gynecological pathology.
- Recognize unusual but important breast and gynecological disease entities.
- Apply immunohistochemical and molecular genetic ancillary studies for diagnosis and differential diagnoses.
- Understand the clinical implications when applying new diagnostic knowledge.
Store-listed materials: 14 videos; the short description also lists PDFs. The delivered counts and format have not been independently verified.
Course Overview
As major subspecialty practices, diagnostic breast and gynecological pathology involves a large number of disease entities and often complex histological variants. Recent developments, particularly molecular genetic discoveries, have introduced new and reclassified entities as well as refined diagnostic criteria for many existing disease processes, calling for a knowledge update for practicing pathologists. While providing comprehensive coverage, the systematic review course emphasizes knowledge acquisitions in morphologic recognition and using ancillary immunohistochemistry and molecular genetic studies in the most challenging areas, particularly new disease classifications/diagnostic criteria.
The original listing describes a CAPA–USCAP collaboration. This store purchase is for study files, not publisher enrollment, live faculty interaction or a USCAP account.
Listed Topics and Faculty
Session labels are retained from the original listing; they are not a verified manifest of delivered files.
-
-
Rare Breast Lesions (that all pathologists should know) – Edi Brogi, MD, PhD
-
Atypical and Metastatic Breast Lesions – Popi Siziopikou, MD, PhD
-
Pathology of the Uterine Corpus – Pei Hui, MD, PhD
-
Pathology of the Vulva, Vagina, and Cervix – Bin Yang, MD, PhD
-
Pathology of the Ovary – Anais Malpica, MD
-
Panel Discussions
